• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卵巢癌综合治疗的进展]

[Advances in the comprehensive treatment of ovarian cancer].

作者信息

Yakushiji M, Sugiyama T

机构信息

Dept. of Obstetrics and Gynecology, Kurume University School of Medicine.

出版信息

Gan To Kagaku Ryoho. 1988 Jun;15(6):1855-62.

PMID:2454614
Abstract

In recent years, chemotherapy has markedly advanced after cisplatin became available. In addition, it has recently been found that the efficacy of chemotherapy differs according to the diameter of the residual tumor (less than 2 approximately 3 cm). For these reasons, debulking or cytoreduction surgery has been frequently carried out in advanced cancer cases to reduce the diameter of tumors. Basic procedures adopted by an increasing number of medical institutions are bilateral adnexectomy + simple total hysterectomy and omentectomy. In addition, since lymph node metastasis is found even in early cancer cases, dissection of lymph nodes extending from the pelvic lymph node to the paraaortic lymph node is now considered to be essential, and is referred to also by the FIGO's new classification of cancer stages. SLO is also important in judging the necessity of excising a residual tumor and assessing therapeutic efficacy. In chemotherapy, high effectiveness rates have been reported chiefly for cisplatin + CAP therapy in epithelial tumor cases and cisplatin + VAC or VBP therapy in germ cell tumor cases. However, since the effect of cisplatin in second and third lines is not satisfactory, development of new platinum compounds and studies of more effective regimens (such as massive cisplatin therapy) are now being performed. Radiation therapy, on the other hand, is merely an auxiliary therapy at present.

摘要

近年来,自顺铂问世后化疗有了显著进展。此外,最近发现化疗疗效因残留肿瘤直径不同而有所差异(小于2至3厘米左右)。基于这些原因,在晚期癌症病例中经常进行肿瘤减积或细胞减灭手术以缩小肿瘤直径。越来越多医疗机构采用的基本手术方式是双侧附件切除术 + 单纯全子宫切除术及大网膜切除术。另外,由于即使在早期癌症病例中也会发现淋巴结转移,现在认为从盆腔淋巴结到腹主动脉旁淋巴结的淋巴结清扫至关重要,国际妇产科联盟(FIGO)癌症分期新分类中也提及了这一点。血清乳酸脱氢酶(SLO)在判断切除残留肿瘤的必要性及评估治疗效果方面也很重要。在化疗方面,上皮性肿瘤病例中主要是顺铂 + 环磷酰胺、阿霉素、顺铂(CAP)疗法,生殖细胞肿瘤病例中是顺铂 + 长春新碱、放线菌素D、环磷酰胺(VAC)或顺铂、博来霉素、长春新碱(VBP)疗法,均报告有较高有效率。然而,由于顺铂在二线和三线治疗中的效果不尽人意,目前正在研发新的铂类化合物并研究更有效的治疗方案(如大剂量顺铂疗法)。另一方面,放射治疗目前仅仅是一种辅助治疗。

相似文献

1
[Advances in the comprehensive treatment of ovarian cancer].[卵巢癌综合治疗的进展]
Gan To Kagaku Ryoho. 1988 Jun;15(6):1855-62.
2
[Treatment of ovarian cancer].[卵巢癌的治疗]
Gan No Rinsho. 1989 Jan;Spec No:392-8.
3
[Radical surgery for ovarian cancer].
Gan To Kagaku Ryoho. 1992 Oct;19(12):1977-81.
4
Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.
Obstet Gynecol. 1989 Jan;73(1):61-5.
5
[Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].[化疗对上皮性卵巢癌淋巴结转移的临床疗效分析]
Ai Zheng. 2003 Apr;22(4):424-7.
6
[Studies of second-look operations (SLO) in ovarian cancer].[卵巢癌二次探查手术(SLO)的研究]
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-2):1310-6.
7
Current status of the second-look operation in ovarian cancer.卵巢癌二次探查术的现状
Clin Obstet Gynaecol. 1983 Aug;10(2):245-59.
8
[Changes in CA125 concentration in ovarian cancer patients during the remission state--mean attenuating curve and the effectiveness of surgery and chemotherapy].卵巢癌患者缓解期CA125浓度变化——平均衰减曲线及手术与化疗的疗效
Nihon Sanka Fujinka Gakkai Zasshi. 1989 May;41(5):537-42.
9
[Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide].[卵巢内胚窦瘤对顺铂、长春新碱和博来霉素或长春新碱、放线菌素和环磷酰胺联合化疗的反应]
Zhonghua Fu Chan Ke Za Zhi. 1995 May;30(5):265-9.
10
[Treatment and overview for the improvement of prognosis in ovarian cancer].[改善卵巢癌预后的治疗与概述]
Gan No Rinsho. 1990 Aug;36(10):1199-205.